ROVRAL LIQUID FUNGICIDE Austrālija - angļu - APVMA (Australian Pesticides and Veterinary Medicines Authority)

rovral liquid fungicide

fmc australasia pty ltd - iprodione; liquid hydrocarbon - emulsion - oil in water - iprodione carbamate active 250.0 g/l; liquid hydrocarbon solvent other 332.0 g/l - fungicide - almond | apricot | boysenberry | canola | celery | cherry | grape | kiwi fruit | lettuce | lucerne | macadamia | mandarin (non-b - alternaria leaf blight or spot blight | black leaf blight | blossom blight - botrytis spp. | blossom blight - monilinia laxa | botrytis | brown rot - monilinia spp. | brown rot - sclerotinia spp. | brown spot on mandarin | early blight or target blackspot | grey mould - botrytis cinerea | hypocotyl rot on potato | lucerne leaf spot | pepper scorch or spot | sclerotinia dropcollar rot of lettuce | sclerotinia rot on peanut | sclerotinia wilt or stem rot | alternaria leaf spot | alternata spot | black scurf | blossom blight | botrytis blight | botrytis rot | brown rot | brown spot | bunch rot | bunch rot-grey mould | grey mould | grey mould (nesting) | leaf spot - alternaria spp. | leptosphaerulina leaf spot | pink rot | post-harvest rot | sclerotinia nest | sclerotinia rot | storage rot | target spot | watery soft rot | white mould

Estreva 0.1% gel Malta - angļu - Medicines Authority

estreva 0.1% gel

laboratoire theramex 6 avenue albert ii, b.p. 59, 98007 monaco cedex, monaco - estradiol - gel - estradiol 1 mg/g - sex hormones and modulators of the genital system

NiQuitin 14 mg transdermal patches Lielbritānija - angļu - myHealthbox

niquitin 14 mg transdermal patches

omega pharma ltd - nicotine - transdermal patch. - 78 mg/15 cm2 - anti-smoking agents - niquitin patches relieve and/or prevent craving and nicotine withdrawal symptoms associated with tobacco dependence. they are indicated to aid smokers wishing to quit or reduce prior to quitting, to assist smokers who are unwilling or unable to smoke, and as a safer alternative to smoking for smokers and those around them. niquitin patches are indicated in pregnant and lactating women making a quit attempt. if possible, when stopping smoking, niquitin patches should be used in conjunction with a behavioural support programme

NiQuitin 21 mg transdermal patches Lielbritānija - angļu - myHealthbox

niquitin 21 mg transdermal patches

omega pharma ltd - nicotine - transdermal patch. - 114 mg/22 cm2 - anti-smoking agents - niquitin patches relieve and/or prevent craving and nicotine withdrawal symptoms associated with tobacco dependence. they are indicated to aid smokers wishing to quit or reduce prior to quitting, to assist smokers who are unwilling or unable to smoke, and as a safer alternative to smoking for smokers and those around them. niquitin patches are indicated in pregnant and lactating women making a quit attempt. if possible, when stopping smoking, niquitin patches should be used in conjunction with a behavioural support programme.

 NiQuitin 7 mg transdermal patches Lielbritānija - angļu - myHealthbox

niquitin 7 mg transdermal patches

omega pharma ltd - nicotine - transdermal patch. - 36 mg/ 7 cm2 - anti-smoking agents - niquitin patches relieve and/or prevent craving and nicotine withdrawal symptoms associated with tobacco dependence. they are indicated to aid smokers wishing to quit or reduce prior to quitting, to assist smokers who are unwilling or unable to smoke, and as a safer alternative to smoking for smokers and those around them. niquitin patches are indicated in pregnant and lactating women making a quit attempt. if possible, when stopping smoking, niquitin patches should be used in conjunction with a behavioural support programme

NiQuitin Clear 14mg Lielbritānija - angļu - myHealthbox

niquitin clear 14mg

omega pharma ltd - nicotine - transdermal patch. - 78 mg/15 cm2 - anti-smoking agents - niquitin clear relieves and/or prevents craving and nicotine withdrawal symptoms associated with tobacco dependence. it is indicated to aid smokers wishing to quit or reduce prior to quitting, to assist smokers who are unwilling or unable to smoke, and as a safer alternative to smoking for smokers and those around them. niquitin clear is indicated in pregnant and lactating women making a quit attempt. if possible, when stopping smoking, niquitin clear should be used in conjunction with a behavioural support programme.

NiQuitin Clear 7mg Lielbritānija - angļu - myHealthbox

niquitin clear 7mg

omega pharma ltd - nicotine - transdermal patch. - 36 mg/ 7 cm2 - anti-smoking agents - niquitin clear relieves and/or prevents craving and nicotine withdrawal symptoms associated with tobacco dependence. it is indicated to aid smokers wishing to quit or reduce prior to quitting, to assist smokers who are unwilling or unable to smoke, and as a safer alternative to smoking for smokers and those around them. niquitin clear is indicated in pregnant and lactating women making a quit attempt. if possible, when stopping smoking, niquitin clear should be used in conjunction with a behavioural support programme.

NiQuitin Clear 21mg Patch Lielbritānija - angļu - myHealthbox

niquitin clear 21mg patch

omega pharma ltd - nicotine - transdermal patch. - 114 mg/22 cm2 - anti-smoking agents - niquitin clear relieves and/or prevents craving and nicotine withdrawal symptoms associated with tobacco dependence. it is indicated to aid smokers wishing to quit or reduce prior to quitting, to assist smokers who are unwilling or unable to smoke, and as a safer alternative to smoking for smokers and those around them. niquitin clear is indicated in pregnant and lactating women making a quit attempt. if possible, when stopping smoking, niquitin clear should be used in conjunction with a behavioural support programme.

Lutrate 1 month Depot 3.75 mg powder and solvent for prolonged-release suspension for injection Lielbritānija - angļu - myHealthbox

lutrate 1 month depot 3.75 mg powder and solvent for prolonged-release suspension for injection

mercury pharmaceuticals limited - leuprorelin acetate - powder and solvent for prolonged-release suspension for injection - 3.75 mg - endocrine therapy. hormones and related agents. gonadotropin-releasing hormones analogues - lutrate 1 month depot is indicated for palliative treatment of locally advanced or metastatic prostate cancer.